Mark McLaughlin

1.4k total citations
32 papers, 510 citations indexed

About

Mark McLaughlin is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Mark McLaughlin has authored 32 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 7 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in Mark McLaughlin's work include Asymmetric Hydrogenation and Catalysis (6 papers), HIV/AIDS drug development and treatment (6 papers) and Catalytic C–H Functionalization Methods (5 papers). Mark McLaughlin is often cited by papers focused on Asymmetric Hydrogenation and Catalysis (6 papers), HIV/AIDS drug development and treatment (6 papers) and Catalytic C–H Functionalization Methods (5 papers). Mark McLaughlin collaborates with scholars based in United States, India and China. Mark McLaughlin's co-authors include Ian W. Davies, Michael Palucki, Cheng‐yi Chen, Robert A. Reamer, Kevin M. Belyk, Yingju Xu, Karen Marcantonio, Jongrock Kong, Ryan J. Mondschein and Feng Peng and has published in prestigious journals such as The Journal of Organic Chemistry, Chemistry - A European Journal and Organic Letters.

In The Last Decade

Mark McLaughlin

28 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark McLaughlin United States 14 374 145 95 50 42 32 510
Robert E. Waltermire United States 13 458 1.2× 220 1.5× 88 0.9× 40 0.8× 48 1.1× 22 594
Khateeta M. Emerson United States 11 285 0.8× 176 1.2× 74 0.8× 43 0.9× 26 0.6× 18 427
Dácil Hernández Spain 16 655 1.8× 280 1.9× 88 0.9× 33 0.7× 26 0.6× 34 776
Benoît Moreau Canada 11 590 1.6× 168 1.2× 175 1.8× 29 0.6× 21 0.5× 20 716
Gregory L. Karrick United States 8 238 0.6× 165 1.1× 55 0.6× 27 0.5× 33 0.8× 11 350
Thomas P. Kissick United States 14 424 1.1× 280 1.9× 53 0.6× 26 0.5× 39 0.9× 24 598
Nga M. United States 8 242 0.6× 141 1.0× 75 0.8× 40 0.8× 34 0.8× 15 385
Zhongping Shi United States 13 555 1.5× 250 1.7× 53 0.6× 31 0.6× 26 0.6× 24 716
Kan K. Eng United States 11 382 1.0× 149 1.0× 59 0.6× 17 0.3× 41 1.0× 13 471
Alan Millar United States 10 379 1.0× 159 1.1× 53 0.6× 37 0.7× 13 0.3× 16 511

Countries citing papers authored by Mark McLaughlin

Since Specialization
Citations

This map shows the geographic impact of Mark McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark McLaughlin more than expected).

Fields of papers citing papers by Mark McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark McLaughlin. The network helps show where Mark McLaughlin may publish in the future.

Co-authorship network of co-authors of Mark McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark McLaughlin. A scholar is included among the top collaborators of Mark McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark McLaughlin. Mark McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Niki R., Mark A. Huffman, Xiao Wang, et al.. (2020). Cover Feature: Five‐Step Enantioselective Synthesis of Islatravir via Asymmetric Ketone Alkynylation and an Ozonolysis Cascade (Chem. Eur. J. 62/2020). Chemistry - A European Journal. 26(62). 14023–14023. 1 indexed citations
2.
Patel, Niki R., Christopher C. Nawrat, Mark McLaughlin, et al.. (2020). Synthesis of Islatravir Enabled by a Catalytic, Enantioselective Alkynylation of a Ketone. Organic Letters. 22(12). 4659–4664. 18 indexed citations
3.
Nawrat, Christopher C., Aaron M. Whittaker, Mark A. Huffman, et al.. (2020). Nine-Step Stereoselective Synthesis of Islatravir from Deoxyribose. Organic Letters. 22(6). 2167–2172. 18 indexed citations
4.
McLaughlin, Mark, Jongrock Kong, Kevin M. Belyk, et al.. (2017). Enantioselective Synthesis of 4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) via Enzymatic Desymmetrization. Organic Letters. 19(4). 926–929. 43 indexed citations
5.
Peng, Feng, Yonggang Chen, Cheng‐yi Chen, et al.. (2017). Asymmetric Formal Synthesis of the Long-Acting DPP-4 Inhibitor Omarigliptin. The Journal of Organic Chemistry. 82(17). 9023–9029. 17 indexed citations
6.
Yasuda, Nobuyoshi, et al.. (2016). Process Chemistry in Antiviral Research. Topics in Current Chemistry. 374(6). 77–77. 2 indexed citations
7.
Peng, Feng, Mark McLaughlin, Yizhou Liu, et al.. (2016). A Mild Cu(I)-Catalyzed Oxidative Aromatization of Indolines to Indoles. The Journal of Organic Chemistry. 81(20). 10009–10015. 22 indexed citations
8.
Cleator, Ed, Mark McLaughlin, Brian Bishop, et al.. (2016). Two Approaches to the Chemical Development and Large-Scale Preparation of a Pyrimidyl Tetrazole Intermediate. Organic Process Research & Development. 20(6). 1075–1087. 13 indexed citations
9.
McLaughlin, Mark, Kevin M. Belyk, Cheng‐yi Chen, et al.. (2013). Practical Asymmetric Synthesis of a Chiral Piperazinone Derivative. Organic Process Research & Development. 17(8). 1052–1060. 24 indexed citations
10.
McLaughlin, Mark, et al.. (2013). Some Items of Interest to Process R & D Chemists and Engineers. Organic Process Research & Development. 17(1). 2–14. 3 indexed citations
11.
McLaughlin, Mark, et al.. (2013). Some Items of Interest to Process R&D Chemists and Engineers. Organic Process Research & Development. 17(7). 952–962. 2 indexed citations
12.
Linghu, Xin, Brian Bishop, Ed Cleator, et al.. (2012). Process Development and Large-Scale Synthesis of MK-6186, a Non-Nucleoside Reverse Transcriptase Inhibitor for the Treatment of HIV. Organic Process Research & Development. 16(4). 605–611. 6 indexed citations
13.
McLaughlin, Mark, et al.. (2010). Some Items of Interest to Process R&D Chemists and Engineers. Organic Process Research & Development. 14(6). 1276–1286. 1 indexed citations
14.
Xu, Yingju, et al.. (2010). Practical Synthesis of Functionalized 1,5-Disubstituted 1,2,4-Triazole Derivatives. The Journal of Organic Chemistry. 75(24). 8666–8669. 30 indexed citations
15.
McLaughlin, Mark, Karen Marcantonio, Cheng‐yi Chen, & Ian W. Davies. (2008). A Simple, Modular Method for the Synthesis of 3,4,5-Trisubstituted Pyrazoles. The Journal of Organic Chemistry. 73(11). 4309–4312. 53 indexed citations
16.
McLaughlin, Mark, et al.. (2007). Some Items of Interest to Process R&D Chemists and Engineers. Organic Process Research & Development. 11(1). 2–12. 2 indexed citations
17.
Chung, John Y. L., Raymond J. Cvetovich, Mark McLaughlin, et al.. (2006). Synthesis of a Naphthyridone p38 MAP Kinase Inhibitor. The Journal of Organic Chemistry. 71(22). 8602–8609. 18 indexed citations
18.
McLaughlin, Mark, et al.. (2006). Some Items of Interest to Process R&D Chemists and Engineers. Organic Process Research & Development. 10(2). 168–183. 2 indexed citations
19.
Amato, Joseph S., John Y. L. Chung, Raymond J. Cvetovich, et al.. (2005). Synthesis of 1-tert-Butyl-4-chloropiperidine:  Generation of an N-tert-Butyl Group by the Reaction of a Dimethyliminium Salt with Methylmagnesium Chloride. The Journal of Organic Chemistry. 70(5). 1930–1933. 4 indexed citations
20.
McLaughlin, Mark. (1994). Adam Bede: History, Narrative, Culture. 22. 55–84. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert E. Waltermire Breakdown of academic impact, for papers by Khateeta M. Emerson Breakdown of academic impact, for papers by Dácil Hernández Breakdown of academic impact, for papers by Benoît Moreau Breakdown of academic impact, for papers by Gregory L. Karrick Breakdown of academic impact, for papers by Thomas P. Kissick Breakdown of academic impact, for papers by Nga M. Breakdown of academic impact, for papers by Zhongping Shi Breakdown of academic impact, for papers by Kan K. Eng Breakdown of academic impact, for papers by Alan Millar
Rankless by CCL
2026